EMEA-000941-PIP01-10 - paediatric investigation plan

hazel pollen

Key facts

• Active substance:
  hazel pollen
• Therapeutic area:
  Pneumology-allergology
• Decision number:
  P/316/2010
• PIP number:
  EMEA-000941-PIP01-10
• Pharmaceutical form(s):
  Suspension for injection
• Condition(s) / indication(s):
  • Treatment of allergic rhinitis
  • Treatment of rhino-conjuctivitis
• Route(s) of administration:
  Subcutaneous use
• Decision type:
  P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
• Decision date:
  22/12/2010
• Compliance check done:
  No

Decision

P/316/2010: EMA decision of 22 December 2010 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for modified allergen extract of hazel pollen (EMEA-00094...

Adopted Reference Number: EMA/769330/2010